iPump, Inc.

Sandoz announced the introduction of tacrolimus capsules, a generic equivalent of Prograf, in the US. Tacrolimus is an immunosuppressive treatment used to help prevent rejection of a kidney or liver transplant. Sandoz is the first and only company to launch generic tacrolimus in the US, delivering on its strategy of being first–to–market with key products. With the introduction of tacrolimus, Sandoz is expanding patient access to cost–saving transplant treatment options in the U.S.

Thank you to Janet Walton, Deputy Program Director, Volunteers in Health Care/RxAssist for this information.